Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Freenome, Inc. (FRNM) is the issuer whose common stock is covered by an amended beneficial-ownership report from Perceptive Advisors LLC, its managing member Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd., and C2 Life Sciences LLC. Perceptive Advisors and Edelman each reported shared voting and dispositive power over 12,606,053 shares, or 11.3%; these are overlapping attributed positions, not separate holdings. The Master Fund directly holds 12,518,597 shares (11.2%), while C2 directly holds 87,456 shares (0.1%). Neither Perceptive Advisors nor Edelman directly holds shares; each may be deemed to beneficially own shares held by the two entities. The reported percentages are based on 111,500,956 shares outstanding as of November 9, 2026. The statement's event date is September 30, 2026.
Key Figures
Beneficially owned shares:12,606,053 shares (11.3%)Master Fund direct holdings:12,518,597 shares (11.2%)C2 direct holdings:87,456 shares (0.1%)+1 more
4 metrics
Beneficially owned shares12,606,053 shares (11.3%)Perceptive Advisors LLC and Joseph Edelman each reported this overlapping position with shared voting and dispositive power.
Master Fund direct holdings12,518,597 shares (11.2%)Shares directly held by Perceptive Life Sciences Master Fund, Ltd.
C2 direct holdings87,456 shares (0.1%)Shares directly held by C2 Life Sciences LLC.
Common shares outstanding111,500,956 sharesAs of November 9, 2026; basis for the reported ownership percentages.
Key Terms
beneficially own, Shared Voting Power, Shared Dispositive Power
3 terms
beneficially ownregulatory
"may be deemed to beneficially own shares held by the Master Fund and C2"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Powerregulatory
"Shared Voting Power 12,606,053"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Powerregulatory
"Shared Dispositive Power 12,606,053"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many FRNM shares did Perceptive Advisors report owning?
Perceptive Advisors LLC reported beneficial ownership of 12,606,053 Freenome common shares, or 11.3%, with shared voting and dispositive power. Joseph Edelman reported the same amount and percentage through the investment-management relationship; neither directly holds shares.
Which entities directly hold FRNM shares?
Perceptive Life Sciences Master Fund, Ltd. directly holds 12,518,597 shares, and C2 Life Sciences LLC directly holds 87,456 shares. Perceptive Advisors LLC serves as investment manager to both entities, and Joseph Edelman is Perceptive Advisors' managing member.
The names of the persons filing this report (collectively, the "Reporting Persons") with respect to the Common Stock, par value $0.0001 per share (the "Common Stock") of Freenome, Inc. (the "Issuer") are:
(i) Perceptive Advisors LLC ("Perceptive Advisors")
(ii) Joseph Edelman ("Mr. Edelman")
(iii) Perceptive Life Sciences Master Fund, Ltd. (the "Master Fund")
(iv) C2 Life Sciences LLC ("C2")
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is:
51 Astor Place, 10th Floor, New York, NY 10003
(c)
Citizenship:
Perceptive Advisors is a Delaware limited liability company.
Mr. Edelman is a United States citizen.
The Master Fund is a Cayman Islands corporation.
C2 is a New York limited liability company.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
35661P100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Schedule 13G. The ownership percentages reported are based on 111,500,956 shares of Common Stock outstanding as of November 9, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2026.
Neither Perceptive Advisors nor Mr. Edelman directly holds any Common Stock. The Master Fund directly holds 12,518,597 shares of Common Stock, and C2 directly holds 87,456 shares of Common Stock. Perceptive Advisors serves as the investment manager to the Master Fund and C2, and may be deemed to beneficially own shares held by the Master Fund and C2. Mr. Edelman is the managing member of Perceptive Advisors and may be deemed to beneficially own the shares held by the Master Fund and C2.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.